Analyst Research

Report Title Price
Arkema SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
ValuEngine Detailed Valuation Report for ARKAY
Provider: ValuEngine, Inc.
$127.00
Buy
Wright Investors Service Comprehensive Report for Arkema Group
Provider: Wright Reports
$472.00
Buy
Arkema SA (AKE) - Financial and Strategic SWOT Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Arkema SA Issues FY 2012 EBITDA Guidance in Line with I/B/E/S Estimates; Announces Targets for FY 2016


Wednesday, 1 Aug 2012 01:00am EDT 

Arkema SA announced that it expects EBITDA of close to EUR 1 billion for full year 2012. It also announced that its target for 2016 is to reach EBITDA of EUR 1,250 million and revenue of EUR 8 billion. According to I/B/E/S estimates, analyst on average are expecting the Company to report full year 2012 EBITDA of EUR 961.21 million. 

Latest Developments for Arkema SA

Latest Key Developments in Chemicals

Company Quote

Arkema SA
(AKE.PA)
79.11
0.33 +0.42%
11:35am EDT